News & events Upcoming events XXIX International Congress of Neurology and Neurosurgery Oct 14, 2021 - Oct 17, 2021 Punta Cana , Dominican Republic More info and meet us there Webinar: CSF-based biomarkers to support the diagnosis of Alzheimer’s disease Oct 27, 2021 - Oct 27, 2021 Webinar , Belgium More info and meet us there LABCLIN 2021 - Congreso Nacional del Laboratorio Clínico Nov 7, 2021 - Nov 13, 2021 Virtual event , Spain More info and meet us there See all upcoming events Latest news Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 S-IgG assay Aug 18, 2021 Fujirebio Europe announces the CE marking of the Lumipulse G SARS-CoV-2 S-IgG assay, a quantitative antibody assay for a fully automated... Read more Fujirebio Europe launches iAMP® COVID-19 SANO Assay, a molecular detection assay that can be performed in saliva Jun 16, 2021 Gent, Belgium – June 16, 2021: Fujirebio Europe today announced the commercial launch of iAMP COVID-19 SANO (Saliva And Nasopharyngeal... Read more Statement on the impact of coronavirus disease Covid-19 on our operations Jan 19, 2021 The novel coronavirus disease Covid-19 first reported in late 2019 has spread worldwide. At Fujirebio Europe’s Belgian facilities, we are... Read more OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform Dec 8, 2020 Gent, Belgium, December 8, 2020 – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they... Read more Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing Nov 9, 2020 Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)... Read more Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers Sep 4, 2020 Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and... Read more Load More
XXIX International Congress of Neurology and Neurosurgery Oct 14, 2021 - Oct 17, 2021 Punta Cana , Dominican Republic More info and meet us there
Webinar: CSF-based biomarkers to support the diagnosis of Alzheimer’s disease Oct 27, 2021 - Oct 27, 2021 Webinar , Belgium More info and meet us there
LABCLIN 2021 - Congreso Nacional del Laboratorio Clínico Nov 7, 2021 - Nov 13, 2021 Virtual event , Spain More info and meet us there
Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 S-IgG assay Aug 18, 2021 Fujirebio Europe announces the CE marking of the Lumipulse G SARS-CoV-2 S-IgG assay, a quantitative antibody assay for a fully automated... Read more
Fujirebio Europe launches iAMP® COVID-19 SANO Assay, a molecular detection assay that can be performed in saliva Jun 16, 2021 Gent, Belgium – June 16, 2021: Fujirebio Europe today announced the commercial launch of iAMP COVID-19 SANO (Saliva And Nasopharyngeal... Read more
Statement on the impact of coronavirus disease Covid-19 on our operations Jan 19, 2021 The novel coronavirus disease Covid-19 first reported in late 2019 has spread worldwide. At Fujirebio Europe’s Belgian facilities, we are... Read more
OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform Dec 8, 2020 Gent, Belgium, December 8, 2020 – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they... Read more
Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing Nov 9, 2020 Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)... Read more
Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers Sep 4, 2020 Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and... Read more
